The Longevity Bet: Where Evidence Meets Investment

From biomarkers for earlier disease detection to organ-specific aging clocks to new insights into brain health and women's health at midlife, the progress being made in the science of aging and longevity is transforming our understanding of how and why we age—and suggesting new ways we may be able to slow it down. These scientific advances are attracting serious capital, from foundations investing in aging-focused research to venture funds betting that longevity is a major growth sector. Hear from the researchers driving the science, the investors funding its future, and the clinicians marrying what we know works with the latest discoveries.